Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 2/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.48 |
| ▸ | G6PD | P11413 | 1/20 | 0.47 |
| ▸ | IDE | P14735 | 1/20 | 0.47 |
| ▸ | DAO | P14920 | 1/20 | 0.42 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2376239 | 0.83 | ENPP2 (0.72) | ENPP2PTGS2 | |
| SCHEMBL2991047 | 0.82 | PTGS2 (0.67) | ENPP2PTGS2 | |
| SCHEMBL17325518 | 0.77 | ENPP2 (0.46) | ENPP2PTGS2DAO | |
| SCHEMBL22693607 | 0.77 | ENPP2 (0.46) | ENPP2PTGS2G6PDIDEDAO | |
| SCHEMBL22693609 | 0.77 | ENPP2 (0.46) | ENPP2PTGS2G6PDIDEDAO | |
| SCHEMBL7210087 | 0.77 | PTGS2 (0.53) | ENPP2PTGS2 | |
| SCHEMBL13949922 | 0.77 | PTGS2 (0.56) | ENPP2PTGS2DNMT1 | |
| SCHEMBL19869164 | 0.75 | BCHE (0.45) | PTGS2 | |
| SCHEMBL3570249 | 0.75 | PSIP1 (0.56) | DNMT1 | |
| SCHEMBL15221164 | 0.75 | CA2 (0.66) | ENPP2PTGS2DAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8987516-B2 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES, LTD. (JP) | 2015-03-24 | — | — | US | disclosed |
| EP-2468722-B1 | Process for producing arylsulfur halotetrafluorides | UBE INDUSTRIES (JP) | 2014-10-01 | — | — | EP | disclosed |
| EP-2468721-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2014-02-26 | — | — | EP | disclosed |
| EP-2468720-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2013-11-27 | — | — | EP | disclosed |
| EP-2468719-B1 | Process for producing arylsulfur pentafluorides | UBE INDUSTRIES (JP) | 2013-10-16 | — | — | EP | disclosed |
| EP-2137144-B1 | PROCESS FOR PRODUCING ARYLSULFUR PENTAFLUORIDES | UBE INDUSTRIES (JP) | 2013-07-31 | — | — | EP | disclosed |
| US-8399720-B2 | Methods for producing fluorinated phenylsulfur pentafluorides | UBE INDUSTRIES, LTD. (JP) | 2013-03-19 | — | — | US | disclosed |
| EP-2468722-A1 | Process for producing arylsulfur halotetrafluorides | UBE Industries, Ltd. (JP) | 2012-06-27 | — | — | EP | disclosed |
| EP-2468720-A1 | Process for producing arylsulfur pentafluorides | UBE Industries, Ltd. (JP) | 2012-06-27 | — | — | EP | disclosed |
| EP-2468719-A1 | Process for producing arylsulfur pentafluorides | UBE Industries, Ltd. (JP) | 2012-06-27 | — | — | EP | disclosed |
| EP-1910357-A2 | INDOLI ZINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS | Argenta Discovery Limited (GB) | 2008-04-16 | — | — | EP | disclosed |
| US-20080027092-A1 | 1-Acetic Acid-Indole, -Indazole and -Benzimidazole Derivatives Useful for the Treatment of Respiratory Disorders | ASTRAZENECA AB (SE) | 2008-01-31 | — | — | US | disclosed |
| WO-2007031747-A1 | IMDOLIZINE DERIVATIVES AS LIGANDS OF THE CRTH2 RECEPTOR | ARGENTA DISCOVERY LIMITED (GB) | 2007-03-22 | — | — | WO | disclosed |
| WO-2006136859-A2 | INDOLI ZINE DERIVATIVES AND THEIR USE AS CRTH2 ANTAGONISTS | ARGENTA DISCOVERY LIMITED (GB) | 2006-12-28 | — | — | WO | disclosed |
| EP-1699781-A1 | 1-ACETIC ACID-INDOLE, -INDAZOLE AND -BENZIMIDAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF RESPIRATORY DISORDERS | AstraZeneca AB (SE) | 2006-09-13 | — | — | EP | disclosed |
| WO-2005054232-A1 | 1-ACETIC ACID-INDOLE, -INDAZOLE AND-BENZIMIDAZOLE DERIVATIVES USFUL FOR THE TREATMENT OF RESPIRATORY DISORDERS | ASTRAZENECA AB (SE) | 2005-06-16 | — | — | WO | disclosed |
| WO-1997042168-A1 | THIO DERIVATIVES OF HYDROXAMIC ACIDS | ZENECA LIMITED (GB) | 1997-11-13 | — | — | WO | disclosed |
| EP-0230755-B1 | 1-PHENYL-3-BENZAZEPINES | SMITHKLINE BEECHAM CORPORATION (US) | 1990-05-16 | — | — | EP | disclosed |
| US-4707483-A | 1-phenyl-3-benzazepines and their use for treating gastrointestinal motility disorders | SMITHKLINE BECKMAN CORPORATION (US) | 1987-11-17 | — | — | US | disclosed |
| EP-0230755-A1 | 1-Phenyl-3-benzazepines | SMITHKLINE BEECHAM CORPORATION (US) | 1987-08-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080027092-A1 | 1-Acetic Acid-Indole, -Indazole and -Benzimidazole Derivatives Useful for the Treatment of Respiratory Disorders | IDO1, ABAT, ECI1 | ENPP2 798/4885PTGS2 836/4885G6PD 500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.